Proceedings of the National Academy of Sciences · 1987 · 63 citations · 22 references
MedicineHematologyImmunologyHematologic OncologyMolecular OncologyOncogenesHematologic MalignanciesHematopoietic NeoplasmsLymphocyte DevelopmentLymphoid NeoplasmsOncogenic VirusesViral OncogenesInoculationInsertion Site EffectsLeukemia PathologySite-specific InsertionSplenic Hyperplasia
A preleukemic state in mice inoculated with Moloney murine leukemia virus (Mo-MuLV) was characterized. Six to 10 weeks after neonatal inoculation, animals developed mild splenomegaly and generalized hematopoietic hyperplasia. The hyperplasia was evident from myeloid and erythroid progenitor assays. A nonleukemogenic variant, Mo+PyF101 Mo-MuLV, did not induce the hyperplasia; this suggests that the hyperplasia is a necessary event in Mo-MuLV leukemogenesis. Another variant, MF-MuLV, which contains the long terminal repeat of Friend MuLV and causes erythroid leukemia instead of T-cell lymphoma, also induced the preleukemic hyperplasia. A model for Mo-MuLV leukemogenesis is presented in which two infection events are necessary: the first leads to generalized hematopoietic hyperplasia, and the second results in site-specific insertion and long terminal repeat activation of cellular protooncogenes.
22
Plaque assay techniques for murine leukemia viruses
Wallace P. Rowe, Wendell E. Pugh, Janet W. Hartley · Virology · 1970 · 1.3K citations
P A Chatis, Christie A. Holland, Janet W. Hartley et al. · Proceedings of the National Academy of Sciences · 1983 · 246 citations · Full text